In this new whitepaper, discover how ProBio accelerates bispecific antibody development with optimised cell line strategies. This guide highlights proven methods such as two-vector expression systems and NGS‑enabled clone selection to improve purity, productivity, and manufacturing robustness.

You will learn:

  • How to reduce bispecific antibody impurities through chain‑ratio optimisation
  • Methods to enhance clone stability and titre
  • Strategies to shorten CMC timelines using cell‑pool materials

Download your copy of the whitepaper now.